(Q48886768)

16 February 2018

title

Brain catecholamines in schizophrenia -- a good case for noradrenaline. (English)

1 reference

16 February 2018

0 references

Hornykiewicz O

1

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 October 1982

1 reference

16 February 2018

published in

Nature

1 reference

16 February 2018

volume

299

1 reference

16 February 2018

issue

5883

1 reference

16 February 2018

page(s)

484-486

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1038/299484a0

exact match

0 references

cites work

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

1 reference

Noradrenaline modulation of the responses of the cerebellar Purkinje cell to afferent synaptic activity

21 January 2018

1 reference

A neuronal basis for the alerting action of (+)-amphetamine

21 January 2018

1 reference

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

Dopamine receptors and schizophrenia: drug effect or illness?

21 January 2018

1 reference

7 January 2021

DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS

1 reference

7 January 2021

Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine Systems

1 reference

7 January 2021

The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity

1 reference

7 January 2021

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

1 reference

7 January 2021

The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

1 reference

7 January 2021

Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs

1 reference

7 January 2021

Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways

1 reference

7 January 2021

On certain psychopharmacological and physiological differences between schizophrenic and normal persons

1 reference

7 January 2021

Reticular Stimulation and Chlorpromazine: An Animal Model for Schizophrenic Overarousal

1 reference

7 January 2021

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

7 January 2021

Schizophrenia: elevated cerebrospinal fluid norepinephrine

1 reference

7 January 2021

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

1 reference

7 January 2021

The effect of pimozide on CSF norepinephrine in schizophrenia

1 reference

7 January 2021

Biochemical Aspects of Neurotransmission in the Developing Brain

1 reference

7 January 2021

Plastic changes in the adrenergic innervation of the rat septal area in response to denervation.

1 reference

7 January 2021

Growth of intact central adrenergic axons in the denervated lateral geniculate body.

1 reference

7 January 2021

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

1 reference

7 January 2021

Cortical and central atrophy in chronic schizophrenia. A controlled study.

1 reference

7 January 2021

Norepinephrine-dopamine interactions and behavior

1 reference

7 January 2021

Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens

1 reference

7 January 2021

DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison

1 reference

7 January 2021

Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine

1 reference

7 January 2021

Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs

1 reference

7 January 2021

Psychosis associated with clonidine withdrawal

1 reference

7 January 2021

Autonomic and psychic effects of yohimbine hydrochloride

1 reference

7 January 2021

Identifiers

DOI

10.1038/299484A0

1 reference

16 February 2018

Dimensions Publication ID

0 references

1 reference

16 February 2018